IRF1 and neoplasm: Functional studies indicated that lineage plasticity and immune cell heterogeneity were coordinately dysregulated through changes in the expression of the FOXA1 transcription factor, the loss of which was sufficient to induce PD-L1 expression on tumor cells via increased IRF1 expression and its binding to the CD274 promoter.